In November 2025, the US Food and Drug Administration (FDA) approved epcoritamab with rituximab and lenalidomide...

Welcome to The Medical Independent Clinical Podcast Series, where we chat to experts to empower healthcare...

It has been a pivotal year in the area of Alzheimer’s disease (AD). In May, the...

Welcome to The Medical Independent Clinical Podcast Series, where we chat to experts to empower healthcare...

Scientists from Trinity College Dublin have discovered that electrical stimulation modulates human macrophage function to favour...

A study presented at the recent European Emergency Medicine (EUSEM) Congress found liquid or powder nasal...

Scientists have discovered how cells in the small intestine of coeliac patients communicate with one another...

Patients with pancreatic cancer continue to face a poor prognosis, with just 13 per cent of...

Approximately 7 per cent of individuals worldwide suffer from functional dyspepsia (FD), according to the results...

Results from the international phase 3 Amplitude trial, presented at the 2025 American Society of Clinical...

Last month, the European Hematology Association (EHA) and the European Myeloma Network (EMN) issued new guidelines...

In April 2025, the National Cancer Control Programme (NCCP) published new evidence-based recommendations on the active...